Cercar

01/03/2025 Cardiac denervation and morpho-functional changes, two sides of the same coin in wild-type transthyretin amyloid cardiomyopathy?
Flotats, A. Cardiac denervation and morpho-functional changes, two sides of the same coin in wild-type transthyretin amyloid cardiomyopathy?. JOURNAL OF NUCLEAR CARDIOLOGY. 2025; 45DOI:10.1016/j.nuclcard.2025.102145. PMID:39870299. IF:2.700(Q2/4D).
14/01/2025 Posterior Cortical Atrophy Due to Alzheimer Disease in a Person With Down Syndrome
Rodríguez-Baz, I, Benejam, B, Morcillo-Nieto, AO, Vaqué-Alcázar, L, Arriola-Infante, JE, Camacho, V, Aranha, MR, Carmona-Iragui, M, Videla, L, Barroeta, I, Fernández, S, Zsadanyi, SE, Giménez, S, Arranz, J, Blesa, LM, Alcolea, D, Lleó, A, Bejanin, A, Fortea, J. Posterior Cortical Atrophy Due to Alzheimer Disease in a Person With Down Syndrome. NEUROLOGY. 2025; 104(1)DOI:10.1212/WNL.0000000000210179. PMID:39689339. IF:8.500(Q1/1D).
01/09/2024 Clinical management of patients with Perugini grade 1 on [99mTc]-HDP cardiac scintigraphy
Calahorro, MC, Stefaneli, P, Camacho, V, Velasco, M, Duch, J, Fern ndez, A, Soldevila, C, Guzm n, G, Castej n, S, Maestro, A, Mirabet, S, Flotats, A. Clinical management of patients with Perugini grade 1 on [99mTc]-HDP cardiac scintigraphy. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2024; 51DOI:. PMID:. IF:7.600(Q1/1D).
01/09/2024 Clinical impact of [18F]FDG PET/CT for initial staging in breast cancer patients prior to neoadjuvant chemotherapy
Renom, JD, Stefaneli, P, Calls, M, Camacho, V, Guzm n, G, Andr s, M, Le n, AF, Soldevila, C, Velasco, M, Castej n, S, Flotats, A. Clinical impact of [18F]FDG PET/CT for initial staging in breast cancer patients prior to neoadjuvant chemotherapy. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2024; 51DOI:. PMID:. IF:7.600(Q1/1D).
01/09/2024 [18F]FDG-PET/CT in Giant Cell Arteritis. Which vascular segmental quantitative parameter is most useful?
Nu o, MV, Fern ndez-Le n, A, Alvarado, PM, Stefaneli, P, Calahorro, MC, Park, HS, Barros-Membrilla, A, Prudencio, GG, Camacho, V, Duch, J, Soldevila-Lozano, C, Echevarne, SC, Lopez, BM, Barranco, IC, Mendez, HC, Macias, HC, Flotats, A. [18F]FDG-PET/CT in Giant Cell Arteritis. Which vascular segmental quantitative parameter is most useful?. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2024; 51DOI:. PMID:. IF:7.600(Q1/1D).
01/09/2024 Tau PET deposition measured by [18F]PI-2620 increases along the Alzheimer's disease continuum in Down Syndrome
Camacho, V, Vaqu , L, Stefaneli, P, Calls, M, Fernandez, A, Duch, J, Barroeta, I, Carmona, M, Velasco, M, Soldevila, C, Guzm n, G, Castej n, S, Bejanin, A, Lle , A, Fortea, J, Flotats, A. Tau PET deposition measured by [18F]PI-2620 increases along the Alzheimer's disease continuum in Down Syndrome. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2024; 51DOI:. PMID:. IF:7.600(Q1/1D).
01/09/2024 Prediction of patient progression-free survival with 177Lu-DOTATATE in clinical practice: NEPTUNESEPTRALU model for patient selection
Casanovas, MM, L pez, J, Jimenez-Fonseca, P, Pubul, V, Bello, P, Garc a-Burillo, A, Valverde, R, Llana, B, Percovich, J, Soldevila, C, Arbizu, J, Pi eiro, A, Castell n, M, Ordu a, P, Cano, J, Tabuenca, M, Rodado, S, Garcia-Ca amaque, L, Nevares, M, Balaguer, D, Gomez, D, Hernando, J, Repetto, A, Nogareda, Z, Carmona-Bayonas, A. Prediction of patient progression-free survival with 177Lu-DOTATATE in clinical practice: NEPTUNESEPTRALU model for patient selection. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2024; 51DOI:. PMID:. IF:7.600(Q1/1D).
01/09/2024 Interobserver agreement in the visual analysis of brain PET/CT studies with Tau tracer [18F]PI-2620 in patients with Down syndrome.
Mormandi, PS, Ballester, PZ, Calls, M, Aguirre, SR, Leon, AF, Guzman, G, Lozano, CS, Castejon, S, Nu o, MV, Duch, J, Fortea, J, Camacho, V, Giralt, AF. Interobserver agreement in the visual analysis of brain PET/CT studies with Tau tracer [18F]PI-2620 in patients with Down syndrome.. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2024; 51DOI:. PMID:. IF:7.600(Q1/1D).